| Tamoxifen retinopathy. A case report. | |
| | |
MedLine Citation:
|
PMID: 2131119 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Tamoxifen is one of the most effective anti-estrogens for breast carcinoma therapy and has been used since 1971. Side effects are not frequent, but some ophthalmologic complications have already been described such as retinopathy, keratopathy and optic neuritis. The authors report a case of retinopathy occurring after a period of 7 years (205 g total doses). They give a review of the literature, with the ophthalmological and functional aspects of the retinopathy. |
| | |
Authors:
|
R H Costa; M R Dhooge; F Van Wing; A F De Rouck |
Related Documents
:
|
1987659 - The synergism of atropine and the cholinesterase reactivator hi-6 in counteracting leth... 18819779 - Zolpidem-induced amnesia and somnambulism: rare occurrences? 17039659 - Etanercept responsive acrodermatitis continua of hallopeau: is a pattern developing? 22929039 - Larval morphology, development and forensic importance of synthesiomyia nudiseta (dipte... 23356699 - Rameses publication standards: meta-narrative reviews. 17057269 - Oxybutynin: dry days for patients with hyperhidrosis. 8688659 - Interruption of breast feeding caused by the presence of neonatal teeth. 20409409 - Multiple pilomatricomas: case presentation and review of the literature. 20494549 - Intravenous lobular capillary hemangioma. |
Publication Detail:
|
Type: Case Reports; Journal Article; Review |
Journal Detail:
|
Title: Bulletin de la Société belge d'ophtalmologie Volume: 238 ISSN: 0081-0746 ISO Abbreviation: Bull Soc Belge Ophtalmol Publication Date: 1990 |
Date Detail:
|
Created Date: 1991-12-03 Completed Date: 1991-12-03 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 7505353 Medline TA: Bull Soc Belge Ophtalmol Country: BELGIUM |
Other Details:
|
Languages: eng Pagination: 161-8 Citation Subset: IM |
Affiliation:
|
Department of Ophthalmology, University of Ghent. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Breast Neoplasms / drug therapy Female Humans Macula Lutea / drug effects Middle Aged Retinal Diseases / chemically induced* Tamoxifen / adverse effects*, therapeutic use Time Factors |
| Chemical | |
Reg. No./Substance:
|
10540-29-1/Tamoxifen |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Treatment of chronic macular oedema with low dosage acetazolamide.
Next Document: Lacrimal conjunctivitis.